Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-03-05 @ 8:51 AM
Study NCT ID:
NCT00483158
Status:
COMPLETED
Last Update Posted:
2008-07-29
First Post:
2007-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First Time in Man Study of Finafloxacin Hydrochloride
Sponsor:
MerLion Pharmaceuticals GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FINA-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Michael Seiberling, MD, Prinzipal Study Investigator
Old Organization:
Swiss Pharma Contract, Basel, Switzerland